GR3015797T3 - Amides of 1-(alkoxybenzyl)piperazines, processes for their preparation and pharmaceutical compositions containing them. - Google Patents

Amides of 1-(alkoxybenzyl)piperazines, processes for their preparation and pharmaceutical compositions containing them.

Info

Publication number
GR3015797T3
GR3015797T3 GR950400927T GR950400927T GR3015797T3 GR 3015797 T3 GR3015797 T3 GR 3015797T3 GR 950400927 T GR950400927 T GR 950400927T GR 950400927 T GR950400927 T GR 950400927T GR 3015797 T3 GR3015797 T3 GR 3015797T3
Authority
GR
Greece
Prior art keywords
alkoxybenzyl
piperazines
amides
processes
preparation
Prior art date
Application number
GR950400927T
Other languages
Greek (el)
Inventor
Michel Gaudry
Bruno Pfeiffer
Pierre Renard
De La Faverie Jean-Fran Renaud
Gerard Adam
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of GR3015797T3 publication Critical patent/GR3015797T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Compounds of formula (I): <IMAGE> with R1, R2 and n as defined in the description. Medicaments.
GR950400927T 1991-08-20 1995-04-17 Amides of 1-(alkoxybenzyl)piperazines, processes for their preparation and pharmaceutical compositions containing them. GR3015797T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9110431A FR2680508B1 (en) 1991-08-20 1991-08-20 NOVEL 1- (ALCOXYBENZYL) PIPERAZINE AMIDE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Publications (1)

Publication Number Publication Date
GR3015797T3 true GR3015797T3 (en) 1995-07-31

Family

ID=9416270

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950400927T GR3015797T3 (en) 1991-08-20 1995-04-17 Amides of 1-(alkoxybenzyl)piperazines, processes for their preparation and pharmaceutical compositions containing them.

Country Status (13)

Country Link
US (1) US5340809A (en)
EP (1) EP0533516B1 (en)
JP (1) JPH0676397B2 (en)
AT (1) ATE118212T1 (en)
AU (1) AU648924B2 (en)
CA (1) CA2076443A1 (en)
DE (1) DE69201368T2 (en)
DK (1) DK0533516T3 (en)
ES (1) ES2071458T3 (en)
FR (1) FR2680508B1 (en)
GR (1) GR3015797T3 (en)
NZ (1) NZ244019A (en)
ZA (1) ZA926277B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245712B (en) * 1991-04-09 1994-10-14 Boehringer Mannheim Italia USEFUL HETEROCYCLIC AMINES THERAPY OF ASTHMA AND AIRWAY INFLAMMATION
WO2000051611A1 (en) 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
AU2002243230A1 (en) * 2000-11-20 2002-06-18 Scios Inc. Piperidine/piperazine-type inhibitors of p38 kinase
US7115607B2 (en) * 2001-07-25 2006-10-03 Amgen Inc. Substituted piperazinyl amides and methods of use
WO2018236745A1 (en) 2017-06-20 2018-12-27 Carnot, Llc Compositions and methods for increasing efficiency of cardiac metabolism
KR102042778B1 (en) * 2018-05-02 2019-11-08 이화여자대학교 산학협력단 Novel sodium channel inhibitor compound, preparation method thereof, and pharmaceutical composition for prevention or treatment of sodium channel related diseases containing the same as an active ingredient
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57169478A (en) * 1981-04-10 1982-10-19 Nippon Chemiphar Co Ltd Piperazine derivative
FR2597100A1 (en) * 1986-01-21 1987-10-16 Nippon Shinyaku Co Ltd PYROGLUTAMIDE DERIVATIVES
JPH075545B2 (en) * 1988-08-04 1995-01-25 明治製菓株式会社 Pyrrolidinone compound and cerebral dysfunction improving agent
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use
EP0385043A1 (en) * 1989-02-28 1990-09-05 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. (Faes) New derivatives of 4-substituted piperazines
FR2669029B1 (en) * 1990-11-14 1994-09-02 Adir NOVEL N-BENZOYL PROLINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
CA2076443A1 (en) 1993-02-21
ZA926277B (en) 1993-03-03
EP0533516A2 (en) 1993-03-24
AU648924B2 (en) 1994-05-05
AU2110792A (en) 1993-02-25
FR2680508B1 (en) 1995-03-03
EP0533516A3 (en) 1993-05-19
ATE118212T1 (en) 1995-02-15
US5340809A (en) 1994-08-23
FR2680508A1 (en) 1993-02-26
EP0533516B1 (en) 1995-02-08
ES2071458T3 (en) 1995-06-16
DE69201368T2 (en) 1995-10-05
DK0533516T3 (en) 1995-07-10
DE69201368D1 (en) 1995-03-23
JPH05208967A (en) 1993-08-20
JPH0676397B2 (en) 1994-09-28
NZ244019A (en) 1995-03-28

Similar Documents

Publication Publication Date Title
ZA926328B (en) Naphthylethylureas and naphthylethylthioureas process for the preparation thereof and pharmaceutical compositions containing them.
ZA926276B (en) 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them.
ZA925128B (en) Pyrrolidine derivatives,their preparation and medicaments containing them
ZA925783B (en) 5-Isoquinolinesulfonamides, process for preparing them and pharmaceutical compositions containing them.
GR3006177T3 (en)
GR3029406T3 (en) Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them.
AU656466B2 (en) New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
IL109610A0 (en) Amide derivatives, their preparation and pharmaceutical compositions containing them
ZA919030B (en) Compounds of n-benzoyl proline,process for their preparation and pharmaceutical compositions containing them
GR3015797T3 (en) Amides of 1-(alkoxybenzyl)piperazines, processes for their preparation and pharmaceutical compositions containing them.
ZA944728B (en) alph -amino acid compounds a process for the preparation thereof and pharmaceutical compositions containing them
NZ243784A (en) N-(isoquinolin-5-ylsulphonyl) azacycloalkane derivatives and pharmaceutical compositions
ZA945423B (en) Substituted piperazines process for the preparation thereof and pharmaceutical compositions containing them
ZA935277B (en) Aminoalkylchromones processes for the preparation thereof and pharmaceutical compositions containing them
IL95166A0 (en) Renin-inhibiting amino oligohydroxy derivatives